Association of stem cell-related markers and survival in astrocytic gliomas

Biomarkers

Volumn 16, Issue 2, 2011, Pages 136-143

  Wan, Feng ^a,b   Herold Mende, Christel ^a   Campos, Benito ^a   Centner, Franz Simon ^a   Dictus, Christine ^a   Becker, Natalia ^c   Devens, Frauke ^c   Mogler, Carolin ^a   Felsberg, Jörg ^d   Grabe, Niels ^a   Reifenberger, Guido ^d   Lichter, Peter ^c   Unterberg, Andreas ^a   Bermejo, Justo Lorenzo ^c,e   Ahmadi, Rezvan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

CI, confidence interval; HR, Hazard ratio; OS, overall survival; p, probability value; rho, spearman rank correlation; SLGCs, stem like glioma cells; TMA, tissue microarray; TSC, Tumour stem cells

Indexed keywords

NESTIN; TRANSCRIPTION FACTOR SOX2;

ADULT; ARTICLE; ASTROCYTOMA; CANCER STEM CELL; CANCER SURVIVAL; CANCER TISSUE; CELL PROLIFERATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADULT; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; LONGITUDINAL STUDIES; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; NERVE TISSUE PROTEINS; PROGNOSIS; SOXB1 TRANSCRIPTION FACTORS; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951893576     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.536256     Document Type: Article

References (24)

1. Al-Hajj M. (2007). Cancer stem cells and oncology therapeutics. Curr Opin Oncol 19: 61-64. (Pubitemid 44885602)
2. Almqvist PM, Mah R, Lendahl U, and et al. (2002). Immunohistochemical detection of nestin in pediatric brain tumours. J Histochem Cytochem 50: 147-158. (Pubitemid 34106754)
3. Bao S, Wu Q, McLendon RE, and et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760. (Pubitemid 44949604)
4. Beier D, Hau P, Proescholdt M, and et al. (2007). CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 67: 4010-4015. (Pubitemid 46815044)
5. Bonnet D, Dick JE.. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737. (Pubitemid 27298715)
6. Colin C, Virard I, Baeza N, and et al. (2007). Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis. Neuropathology and Applied Neurobiology 4: 431-439. (Pubitemid 47037890)
7. Collins AT, Berry PA, Hyde C, and et al. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951. (Pubitemid 41713363)
8. Dahlstrand J, Collins VP and Lendahl U. (1992). Expression of the class VI intermediate filament nestin in human central nervous system tumours. Cancer Res 52: 5334-5341.
9. Dictus C, Tronnier V, Unterberg A and Herold-Mende C. (2007). Comparative analysis of in vitro conditions for rat adult neural progenitor cells. J Neurosci Meth 161: 250-258. (Pubitemid 46466951)
10. Freier K, Bosch FX, Flechtenmacher C, and et al. (2003). Distinct sitespecific oncoprotein overexpression in head and neck squamous cell carcinoma: a tissue microarray analysis. Anticancer Res 23: 3971-3977. (Pubitemid 37474351)
11. Graham V, Khudyakov J, Ellis P and Pevny L.. (2003). SOX2 functions to maintain neural progenitor identity. Neuron 39: 749-765. (Pubitemid 37088088)
12. Karcher S, Steiner HH, Ahmadi R, and et al. (2006). Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 118: 2182-2189.
13. Liu G, Yuan X, Zeng Z, and et al. (2006). Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5: 67.
14. Ma YH, Mentlein R, Knerlich F, and et al. (2008). Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol 86: 31-45. (Pubitemid 350263430)
15. Mao Y, Zhou L, Zhu W, and et al. (2007). Proliferative status of tumor stem cells may be correlated with malignancy grade of human astrocytomas. Front Biosci 12: 2252-2259.
16. Neuzil J, Stantic M, Zobalova R, and et al. (2007). Tumour-initiating cells vs cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun 355: 855-859. (Pubitemid 46366906)
17. Singh SK, Clarke ID, Terasaki M, and et al. (2003). Identification of a cancer stem cell in human brain tumours. Cancer Res 63: 5821-5828. (Pubitemid 37187480)
18. Singh SK, Hawkins C, Clarke ID, et al. (2004). Identification of human brain tumour initiating cells. Nature 432: 396-401. (Pubitemid 39551674)
19. Strojnik T, Røsland GV, Sakariassen PO, and et al. (2007). Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 68: 133-143. (Pubitemid 47087905)
20. Vescovi AL, Galli R and Reynolds BA. (2006). Brain tumour stem cells. Nat Rev Cancer 6: 425-436.
21. Veselska R, Kuglik P, Cejpek P, and et al. (2006). Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer 6:32.
22. Walzlein JH, Synowitz M, Engels B, and et al. (2008). The antitumorigenic response of neural precursors depends on subventricular proliferation and age. Stem Cells 26: 2945-2954.
23. Wang J, Sakariassen Po, Tsinkalovsky O, and et al. (2008). CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 122: 761-768.
24. Zeppernick F, Ahmadi R, Campos B, and et al. (2008). Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 14: 123-129. (Pubitemid 351377986)